[go: up one dir, main page]

BRPI0817230A2 - inactivated influenza vaccine, and use of the vaccine - Google Patents

inactivated influenza vaccine, and use of the vaccine

Info

Publication number
BRPI0817230A2
BRPI0817230A2 BRPI0817230A BRPI0817230A BRPI0817230A2 BR PI0817230 A2 BRPI0817230 A2 BR PI0817230A2 BR PI0817230 A BRPI0817230 A BR PI0817230A BR PI0817230 A BRPI0817230 A BR PI0817230A BR PI0817230 A2 BRPI0817230 A2 BR PI0817230A2
Authority
BR
Brazil
Prior art keywords
vaccine
inactivated influenza
influenza vaccine
inactivated
influenza
Prior art date
Application number
BRPI0817230A
Other languages
Portuguese (pt)
Inventor
Lodewijk Glansbeek Henricus
Gerardus Maria Heldens Jacobus
Original Assignee
Nobilon Int B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobilon Int B V filed Critical Nobilon Int B V
Publication of BRPI0817230A2 publication Critical patent/BRPI0817230A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0817230A 2007-09-24 2008-09-23 inactivated influenza vaccine, and use of the vaccine BRPI0817230A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97456807P 2007-09-24 2007-09-24
EP07117050 2007-09-24
PCT/EP2008/062694 WO2009040343A1 (en) 2007-09-24 2008-09-23 Inactivated influenza vaccine

Publications (1)

Publication Number Publication Date
BRPI0817230A2 true BRPI0817230A2 (en) 2017-06-06

Family

ID=39590199

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817230A BRPI0817230A2 (en) 2007-09-24 2008-09-23 inactivated influenza vaccine, and use of the vaccine

Country Status (6)

Country Link
EP (1) EP2195020A1 (en)
CN (1) CN101808659A (en)
AR (1) AR068536A1 (en)
BR (1) BRPI0817230A2 (en)
TW (1) TW200927928A (en)
WO (1) WO2009040343A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9278999B2 (en) 2012-01-27 2016-03-08 Newport Laboratories Influenza C virus and vaccine
CA2954740C (en) 2014-07-11 2022-10-18 National Research Council Of Canada Sulfated-glycolipids as adjuvants for vaccines
CN104792985A (en) * 2015-04-21 2015-07-22 乾元浩生物股份有限公司 Method for qualitatively and quantitatively analyzing effective components of avian influenza virus antigen for poultry
CA3083576A1 (en) * 2017-09-07 2019-03-14 Hawaii Biotech, Inc. Filovirus vaccine and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
US20090304742A1 (en) * 2005-11-04 2009-12-10 Novartis Vaccines And Diagnostics Srl Influenza vaccines with reduced amount of emulsion adjuvant

Also Published As

Publication number Publication date
AR068536A1 (en) 2009-11-18
TW200927928A (en) 2009-07-01
CN101808659A (en) 2010-08-18
WO2009040343A1 (en) 2009-04-02
EP2195020A1 (en) 2010-06-16

Similar Documents

Publication Publication Date Title
IL186611A0 (en) Vaccine against pandemic strains of influenza viruses
PL2281830T3 (en) VACCINE AGAINST VIRCLE AND SHINESHIP VIRUS
BRPI1011916A2 (en) use of a combination of uv filter, and cosmetic preparation.
BR112012003792A2 (en) topical gel and use of topical gel.
BRPI0909770A2 (en) Vaccine and kit
BRPI0919014A2 (en) fixative makeup, and use of a makeup
BR112012013148A2 (en) pharmaceutical formulation and use
BR112012004335A2 (en) compound, pharmaceutical composition, and use of the compound.
EA201070219A1 (en) POLYMERIC MULTIEPITIC VACCINES AGAINST FLU
AP2008004625A0 (en) Avian influenza viruses, vaccines, compositions, formulations, and methods
DK2069503T3 (en) PAPAYAMOSAIKVIRUS-BASED VACCINES AGAINST INFLUENZA
HUE043952T2 (en) Modified influenza virus to monitor and improve vaccine efficacy
BRPI0914069A2 (en) vaccine composition for use against influenza
BRPI0813627A2 (en) ANTIMICROBIAN PEPTIDIA, COMPOSITIONS AND METHODS OF USE
BRPI0921359A2 (en) Antigens that induce the immune response against flaviviruses and their methods of use.
CR10571A (en) RECOMBINING VIRIC VACCINE
BRPI0821034A2 (en) Modified Influenza Virus
BRPI1008887A2 (en) foxm1 peptides and vaccines containing the same
ZA200809056B (en) Influenza virus vaccine
EP2125500A4 (en) HIV COMBINATION VACCINE AND PRIME BOOST PROCEDURE THEREFOR
BRPI0910570A2 (en) use of bioconjugates and pharmaceutical formulations
PT2408913T (en) NEIL3 PEPTIDES AND VACCINES INCLUDING THE SAME
DK2422810T3 (en) Influenza vaccine
BRPI0815373A2 (en) CYCLE-HEXENE DERIVATIVES AND THE USE OF THEM AS FRAGRANCES
BRPI1014904A2 (en) quinazolinadione derivatives, preparation thereof and various therapeutic uses thereof.

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)